Literature DB >> 9214305

Fluorescence spectral changes during the folding of intestinal fatty acid binding protein.

I J Ropson1, P M Dalessio.   

Abstract

Although large changes in fluorescence intensity are observed during the folding and unfolding of many proteins, it has been difficult to associate these changes with specific structures or with the environmental changes which a particular tryptophan may undergo during these processes. The fluorescence spectral changes that occur during the folding and unfolding of rat intestinal fatty acid binding protein (IFABP) are described here. The intermediate observed during unfolding had spectral characteristics similar to those of unfolded protein, but with somewhat higher intensity. Stopped-flow circular dichroism measurements during unfolding showed that little if any secondary structure was associated with this intermediate. During refolding, the initial fluorescence spectrum was not that of native or unfolded IFABP, suggesting that some structure with intermediate fluorescent properties had formed during the deadtime of mixing. The shape and intensity of this initial spectrum were dependent on the final urea concentration, becoming more native-like at lower final concentrations of denaturant. A simple model for refolding suggests that a portion of the protein molecules obtain native structure and fluorescent characteristics during the deadtime of mixing, and that the remaining protein molecules have spectral characteristics similar to those of the intermediate observed during unfolding. Lower final concentrations of denaturant cause a larger proportion of molecules to follow the rapid refolding pathway. Knowledge of the fluorescence spectral characteristics of the intermediates formed during the folding and unfolding of any protein will improve our understanding of the nature of these structures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9214305     DOI: 10.1021/bi962983b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Properties and crystal structure of a beta-barrel folding mutant.

Authors:  I J Ropson; B C Yowler; P M Dalessio; L Banaszak; J Thompson
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

2.  Residual interactions in unfolded bile acid-binding protein by 19F NMR.

Authors:  H Kenney Basehore; Ira J Ropson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

Review 3.  Roles of beta-turns in protein folding: from peptide models to protein engineering.

Authors:  Anna Marie C Marcelino; Lila M Gierasch
Journal:  Biopolymers       Date:  2008-05       Impact factor: 2.505

4.  Delta98Delta, a minimalist model of antiparallel beta-sheet proteins based on intestinal fatty acid binding protein.

Authors:  Lucrecia María Curto; Julio Javier Caramelo; Gisela Raquel Franchini; José María Delfino
Journal:  Protein Sci       Date:  2009-04       Impact factor: 6.725

5.  Replacement of proline with valine does not remove an apparent proline isomerization-dependent folding event in CRABP I.

Authors:  Lora L Burns-Hamuro; Paula M Dalessio; Ira J Ropson
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

6.  Active-site alkylation destabilizes human O6-alkylguanine DNA alkyltransferase.

Authors:  Joseph J Rasimas; Paula A Dalessio; Ira J Ropson; Anthony E Pegg; Michael G Fried
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

7.  Water and urea interactions with the native and unfolded forms of a beta-barrel protein.

Authors:  Kristofer Modig; Elizabeth Kurian; Franklyn G Prendergast; Bertil Halle
Journal:  Protein Sci       Date:  2003-12       Impact factor: 6.725

8.  Kinetic and thermodynamic studies reveal chemokine homologues CC11 and CC24 with an almost identical tertiary structure have different folding pathways.

Authors:  Baosheng Ge; Xiaoyong Jiang; Yao Chen; Tingting Sun; Qiuxia Yang; Fang Huang
Journal:  BMC Biophys       Date:  2017-09-12       Impact factor: 4.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.